30-90 Day Benefit of Using Interreality Care to Reduce Unnecessary
Hospital Admissions among High-Risk Patients
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Background

Results

Reducing unnecessary hospital admission/ER visits on
HMO/MSO/ACO patients is very challenging beyond
the traditional 30-90 day readmission threshold. Our
study focused on expanding an Interreality (On-Site &
On-Line) Care (IC) model (EHJ 2018;39:S225) in highrisk patients in HMO setting.

Prior to IC, patients with CC had 277 total admission/ER visits compared to 14 during IC.
Of the 46 enrolled patients, IC showed a 80% decrease for ALL admission/ER visits
compared to CC (0.3 ± 0.8 IC vs. 1.5 ± 1.2 CC; p < 0.001*) with a decrease in average
length of stay (LOS) of 5.3 days per admission (0.5 ± 1.7 IC vs. 5.8 ± 5.0 CC; p < 0.001*).

2.0

Of the 57 patients, 11 patients were lost to follow-up
prior to enrollment (n=46). Baseline admission/ER visits
were determined on conventional care provided prior to
enrollment. Of the 46 enrolled patients, admission/ER
visits were normalized by total days of baseline and
compared between conventional care (CC) and IC.
Patients in IC were treated and followed on average for
70 days (70 ± 33 days).

Total ER/Admissions

IC model was created by integrating:
1. On-Site Care: ARNP & testing at patients’ residency;
2. On-Line Care: 24/7 monitoring & specialty
cardiology/pulmonary intervention; and
3. A new high-risk care system with telemedicine,
device, monitoring, protocols & management.
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Methods

2.2

A group of 57 Medicare Advantage patients with
multiple admission/ER visits from 3 different healthcare
organizations were referred to a Management Service
Organization (MSO) due to their increased diagnosis
severity (CHF/COPD) & costs.
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To our knowledge, this is the 1st study to
evaluate and show the possible benefits
of IC on reducing admission/ER visits for
high-risk (CHF/COPD) patients in the
HMO setting. Compared to conventional
analytical and administrative models for
unnecessary admissions, integrating new
technologies to treat high-risk patients
may deliver significant clinical benefits to
healthcare in the 30-90 day setting.
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